---
format: "aidr-story-markdown/v1"
id: "2af71570e29594de12185dd475d7f9b217c4c9a6aec1e3630a4b50a022984906"
canonical_url: "https://aidr.today/2af71570?lang=en"
title: "Albert Invent, which launched an AI model trained on chemical patents and data about 15M molecules, raised a $55M Series B, a source says at a $340M valuation (Rashi Shrivastava/Forbes)"
lang: "en"
requested_lang: "en"
available_langs: ["en","vi"]
translation_fallback: null
fallback_fields: []
published_at: "2026-10-14T00:05:01.000Z"
category: "Funding"
topics: ["funding"]
source_urls: ["https://www.techmeme.com/261013/p48"]
summary: "Albert Invent, which launched an AI model trained on chemical patents and data about 15M molecules, raised a $55M Series B, a source says at a $340M valuation. Scientists at manufacturing conglomerates like Kenvue and Henkel use Albert Invent's AI tools to design experiments."
---

# Albert Invent, which launched an AI model trained on chemical patents and data about 15M molecules, raised a $55M Series B, a source says at a $340M valuation \(Rashi Shrivastava/Forbes\)

> [Open the canonical story](<https://aidr.today/2af71570?lang=en>)

**Published:** 2026-10-14T00:05:01.000Z
**Category:** Funding
**Topics:** funding

## Summary

Albert Invent, which launched an AI model trained on chemical patents and data about 15M molecules, raised a $55M Series B, a source says at a $340M valuation\. Scientists at manufacturing conglomerates like Kenvue and Henkel use Albert Invent's AI tools to design experiments\.

## Sources

- [Story source](<https://www.techmeme.com/261013/p48>)